Cargando…
Dysglycaemia and Other Predictors for Progression or Regression from Impaired Fasting Glucose to Diabetes or Normoglycaemia
Aims. Diabetes mellitus is a growing health problem worldwide. This study aimed to describe dysglycaemia and determine the impact of body composition and clinical and lifestyle factors on the risk of progression or regression from impaired fasting glucose (IFG) to diabetes or normoglycaemia in Austr...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4530268/ https://www.ncbi.nlm.nih.gov/pubmed/26273669 http://dx.doi.org/10.1155/2015/373762 |
_version_ | 1782384888019681280 |
---|---|
author | de Abreu, L. Holloway, Kara L. Kotowicz, Mark A. Pasco, Julie A. |
author_facet | de Abreu, L. Holloway, Kara L. Kotowicz, Mark A. Pasco, Julie A. |
author_sort | de Abreu, L. |
collection | PubMed |
description | Aims. Diabetes mellitus is a growing health problem worldwide. This study aimed to describe dysglycaemia and determine the impact of body composition and clinical and lifestyle factors on the risk of progression or regression from impaired fasting glucose (IFG) to diabetes or normoglycaemia in Australian women. Methods. This study included 1167 women, aged 20–94 years, enrolled in the Geelong Osteoporosis Study. Multivariable logistic regression was used to identify predictors for progression to diabetes or regression to normoglycaemia (from IFG), over 10 years of follow-up. Results. At baseline the proportion of women with IFG was 33.8% and 6.5% had diabetes. Those with fasting dysglycaemia had higher obesity-related factors, lower serum HDL cholesterol, and lower physical activity. Over a decade, the incidence of progression from IFG to diabetes was 18.1 per 1,000 person-years (95% CI, 10.7–28.2). Fasting plasma glucose and serum triglycerides were important factors in both progression to diabetes and regression to normoglycaemia. Conclusions. Our results show a transitional process; those with IFG had risk factors intermediate to normoglycaemics and those with diabetes. This investigation may help target interventions to those with IFG at high risk of progression to diabetes and thereby prevent cases of diabetes. |
format | Online Article Text |
id | pubmed-4530268 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Hindawi Publishing Corporation |
record_format | MEDLINE/PubMed |
spelling | pubmed-45302682015-08-13 Dysglycaemia and Other Predictors for Progression or Regression from Impaired Fasting Glucose to Diabetes or Normoglycaemia de Abreu, L. Holloway, Kara L. Kotowicz, Mark A. Pasco, Julie A. J Diabetes Res Research Article Aims. Diabetes mellitus is a growing health problem worldwide. This study aimed to describe dysglycaemia and determine the impact of body composition and clinical and lifestyle factors on the risk of progression or regression from impaired fasting glucose (IFG) to diabetes or normoglycaemia in Australian women. Methods. This study included 1167 women, aged 20–94 years, enrolled in the Geelong Osteoporosis Study. Multivariable logistic regression was used to identify predictors for progression to diabetes or regression to normoglycaemia (from IFG), over 10 years of follow-up. Results. At baseline the proportion of women with IFG was 33.8% and 6.5% had diabetes. Those with fasting dysglycaemia had higher obesity-related factors, lower serum HDL cholesterol, and lower physical activity. Over a decade, the incidence of progression from IFG to diabetes was 18.1 per 1,000 person-years (95% CI, 10.7–28.2). Fasting plasma glucose and serum triglycerides were important factors in both progression to diabetes and regression to normoglycaemia. Conclusions. Our results show a transitional process; those with IFG had risk factors intermediate to normoglycaemics and those with diabetes. This investigation may help target interventions to those with IFG at high risk of progression to diabetes and thereby prevent cases of diabetes. Hindawi Publishing Corporation 2015 2015-07-27 /pmc/articles/PMC4530268/ /pubmed/26273669 http://dx.doi.org/10.1155/2015/373762 Text en Copyright © 2015 L. de Abreu et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article de Abreu, L. Holloway, Kara L. Kotowicz, Mark A. Pasco, Julie A. Dysglycaemia and Other Predictors for Progression or Regression from Impaired Fasting Glucose to Diabetes or Normoglycaemia |
title | Dysglycaemia and Other Predictors for Progression or Regression from Impaired Fasting Glucose to Diabetes or Normoglycaemia |
title_full | Dysglycaemia and Other Predictors for Progression or Regression from Impaired Fasting Glucose to Diabetes or Normoglycaemia |
title_fullStr | Dysglycaemia and Other Predictors for Progression or Regression from Impaired Fasting Glucose to Diabetes or Normoglycaemia |
title_full_unstemmed | Dysglycaemia and Other Predictors for Progression or Regression from Impaired Fasting Glucose to Diabetes or Normoglycaemia |
title_short | Dysglycaemia and Other Predictors for Progression or Regression from Impaired Fasting Glucose to Diabetes or Normoglycaemia |
title_sort | dysglycaemia and other predictors for progression or regression from impaired fasting glucose to diabetes or normoglycaemia |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4530268/ https://www.ncbi.nlm.nih.gov/pubmed/26273669 http://dx.doi.org/10.1155/2015/373762 |
work_keys_str_mv | AT deabreul dysglycaemiaandotherpredictorsforprogressionorregressionfromimpairedfastingglucosetodiabetesornormoglycaemia AT hollowaykaral dysglycaemiaandotherpredictorsforprogressionorregressionfromimpairedfastingglucosetodiabetesornormoglycaemia AT kotowiczmarka dysglycaemiaandotherpredictorsforprogressionorregressionfromimpairedfastingglucosetodiabetesornormoglycaemia AT pascojuliea dysglycaemiaandotherpredictorsforprogressionorregressionfromimpairedfastingglucosetodiabetesornormoglycaemia |